Thursday, 15 October 2026

iberempresa

IBEX 3519.140,40▼ -0,47%EuroStoxx 506139,28▼ -0,83%S&P 5007709,10▼ -0,13%€/$1,1226▲ +0,62%Brent105,41▼ -0,61%Bitcoin72.545▼ -0,44%
Breaking

Inmunoglobulinas

Latest Inmunoglobulinas news

1 article

Illustrative image: glass vials with golden liquid in a pharmaceutical laboratory lit by side natural light.

Grifols reports €227 million profit in the first half driven by immunoglobulins

Grifols reports a €227 million profit in the first half, up 28.7%, driven by immunoglobulins and operational recovery.